Skip to main content
MedTech Innovator_logo

Syensqo partners with MedTech Innovator to support the next generation of medical device innovation

Share to

Collaboration demonstrates commitment to accelerate early-stage healthcare technologies

Syensqo, a global science company developing breakthrough solutions that advance humanity, today announced it has joined MedTech Innovator (MTI), the world’s largest accelerator for medical device, digital health and diagnostic companies.

MTI is a nonprofit global accelerator whose mission is to improve patients’ lives by accelerating the growth of companies transforming healthcare. Since 2013, it has supported more than 800 best-in-class startups through a model built on visibility, partnership, and mentorship, connecting innovators with a broad ecosystem across the medtech industry. 

By joining MTI, Syensqo is strengthening its engagement with the startup medical device community, bringing its materials and application expertise closer to early-stage development, where design decisions can have an outsized impact on performance, manufacturability, and time-to-market.

As a partner, Syensqo joins MTI at every critical inflection point, from reviewing 1,800+ applications, to engaging with 200+ startup pitches at the Radar Forum (April 7–9) and virtual Radar pitches, participating in the Innovator Summit kickoff in June, supporting virtual accelerator programming, and connecting at the Finals Competitions in October.

Innovation thrives across the healthcare ecosystem, from startups to established leaders, and early development is where great ideas take shape. Through MedTech Innovator, we’re expanding how we support innovators, sharing deep polymer know-how, application experience, and data-driven guidance to help emerging companies reach their product goals and ultimately improve patient care.

Natalie Dragunat, Global Marketing Manager at Syensqo

I’m proud of our long-standing success in discovering and supporting the world’s most promising medical technology and digital health companies. Our carefully curated partners and sponsors serve a vital role in driving innovations to achieve their maximum potential, and we are thrilled to welcome Syensqo as our newest partner. Together, we look forward to improving patient outcomes and creating lasting value across the healthcare ecosystem.

Paul Grand, Founder and CEO of MedTech Innovator

Syensqo delivers one of the industry’s most comprehensive portfolios of medical-grade thermoplastics and implantable biomaterials, supporting applications from critical medical devices and equipment to long-term implantable devices. Backed by more than 60 years of high-performance polymer innovation, Syensqo’s renowned Radel® PPSU and Udel® PSU are trusted worldwide for their exceptional durability, strength and sterilization resistance. Solviva® Biomaterials - including Zeniva® PEEK, Eviva® PSU, and Veriva® PPSU - enable lightweight, radiolucent solutions for advanced implant applications. With a global presence in 30 countries and a team of 13,000 employees, Syensqo partners with medical device and equipment manufacturers through deep technical expertise and a broad materials portfolio.

Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.

Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and healthcare applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.

Learn more at www.syensqo.com.

MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing over 15,000 applicants and fostering the growth of 838 graduates. Alumni have collectively raised $11 billion in follow-on funding and introduced 500+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow MTI on LinkedIn, and subscribe to its monthly newsletter.